Phathom Pharmaceuticals Inc (PHAT)
10.28
+0.61
(+6.31%)
USD |
NASDAQ |
May 14, 14:11
Phathom Pharmaceuticals Gross Profit Margin (Quarterly): 77.72% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 77.72% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
77.72%
Minimum
Mar 2024
77.72%
Maximum
Mar 2024
77.72%
Average
77.72%
Median
Mar 2024
Gross Profit Margin (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 86.21% |
Ocular Therapeutix Inc | 91.02% |
Rhythm Pharmaceuticals Inc | 89.19% |
Xeris Biopharma Holdings Inc | 82.95% |
Gritstone Bio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Profit Margin (Quarterly) | -4.33K% |
Operating Margin (Quarterly) | -3.66K% |